In PD, dopaminergic treatment has been shown to affect ACE levels in the cerebrospinal fluid (CSF) [148], and perindopril,-an ACE inhibitor- treatment, may improve motor symptoms in levodopa-treated PD patients [149]. This evidence concerns the gene ACE and Parkinson disease.